Slide background

Slide background
Slide background
Slide background

Loading Events
March
2020
3
New York Cancer Genomics Research Network Meeting

5:00 PM — 8:00 PM

Moderated by Harold Varmus, MD

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

To advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions.

 

WHEN:
Tuesday, March 3, 2020
5:00 PM – 7:00 PM: Speaker Presentations and Q&A
7:00 PM – 8:00 PM: Hors d’oeuvres & Networking

 

WHERE:
New York Genome Center
101 Avenue of the Americas, 1st Floor Auditorium

 

REGISTER

 

MODERATOR
Harold Varmus, MD 
Senior Associate Core Member
New York Genome Center

Lewis Thomas University Professor of Medicine
Weill Cornell Medicine

 

 

 

 

SPEAKERS

Ross L. Levine, MD
Laurence Joseph Dineen Chair in Leukemia Research
Director, MSK Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center

 

Ross Levine is a Member of the Human Oncology and Pathogenesis Program, an Attending Physician on the Leukemia Service, Department of Medicine at Memorial Sloan Kettering (MSK), and the Chief of the Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program.  He is the Laurence Joseph Dineen Chair in Leukemia Research, a Professor of Medicine at Weill Cornell Medical College, and the Director of the MSK Center for Hematologic Malignancies. Dr. Levine earned his A.B. from Harvard College and a M.D. from Johns Hopkins. Dr. Levine served as a Resident in Internal Medicine at Massachusetts General Hospital and as a Hematology-Oncology Fellow at Dana-Farber Cancer Institute. His laboratory has identified myeloproliferative neoplasm (MPN) predisposition alleles and characterized somatic genetic and epigenetic alterations in MPN and acute myeloid leukemia (AML) patients, which has led to new mechanism based therapies.  He has been honored with the Dameshek Prize from the American Society of Hematology, a Scholar Award from the Leukemia and Lymphoma Society, the Boyer Award for Clinical Investigation from Memorial Sloan Kettering Cancer Center, and a NCI Outstanding Investigator R35 Award.  In 2011 he was elected to the American Society of Clinical Investigation and in 2018 to the Association of American Physicians. He serves on the Supervisory Board of Qiagen and on the Scientific Advisory Board of C4 Therapeutics, Isoplexis, Mana Therapeutics and was on the Scientific Advisory Board of Loxo Oncology.

To learn more about Dr. Levine’s research, visit his lab page.

 

 

Paz Polak, PhD
Assistant Professor
Department of Oncological Sciences
Icahn School of Medicine at Mount Sinai

 

“How Can Passenger Mutations Inform on the Cell of Origin?”

 

Paz Polak, Ph.D. is an Assistant Professor in the Department of Oncological Sciences at the Icahn School of Medicine at Mount Sinai Hospital. His lab focus is on the etiology of breast cancer across different populations via multiple genomic and computational techniques. Currently, Dr. Polak lab studies the genomes of Caribbean and African American cancer patients in the US. Dr. Polak also intends to study cancer genomes of the different populations via international partnerships with cancer researchers from Brazil, Ghana, and the Dominican Republic.

To learn more about Dr. Polak’s research, visit his profile page.

 

 

 

Kwok-Kin Wong, MD, PhD
Anne Murnick Cogan and David H. Cogan Professor of Oncology, Department of Medicine
Director, Division of Hematology and Medical Oncology
NYU Langone Health

 

 

To learn more about Dr. Wong’s research, visit his lab page.

 

 

 

Discussion and Q&A
Moderated by Harold Varmus, MD
Discussion and Q&A will take place after each speaker presents.
These meetings are held on the first Tuesday of each month and are intended for principal investigators in the New York region and their trainees.
Any questions on this event, contact events@nygenome.org.

 

 

  • EVENING TALKS
    The New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:00 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.

  • Workshops
  • Computational Cancer Genomics Working Group Evening Lectures
    Computational Cancer Genomics Working Group is led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center. This group will build collaborations that apply novel statistical approaches and population-level analyses to major cohorts in cancer genomics.

  • Neurodegenerative Disease Working Group Evening Lectures
    The NYGC is leveraging the success of the Center for Genomics of Neurodegenerative Disease (CGND) to extend our work across a range of neurodegenerative diseases that have pathways in common with ALS, including Alzheimer’s, Parkinson’s and Huntington’s diseases. The NYGC has created a new Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center, with the objective of bringing together researchers from NYGC’s institutional founding members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neurodegenerative disease.

  • Neuropsychiatric Disease Working Group Evening Lectures
    The NYGC has created a new scientific working group with the objective of bringing together researchers from our Institutional Founding Members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neuropsychiatric disease.